Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-29

Clinical Trial Update: ATP in Alzheimer Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ATP for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATP (adenosine triphosphate)

Snippet

Sponsor: Sara Varea | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED